Methods and compositions for preparing capped RNA

Inactive Publication Date: 2005-12-29
ASURAGEN
View PDF5 Cites 41 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0018] Methods of the invention generally involve providing a relatively low concentration of the nucleotide that competes with the cap analog and adding the competing nucleotide at least one time after an initial batch reaction or continuously during the reaction. The “relatively low concentration” is relative to the concentration of the cap analog in the reaction. Thus, embodiments of the invention involve keeping the amount of the competing nucleotide in the reaction w

Problems solved by technology

Increasing the ratio of cap analog to GTP in the transcription reaction produces lower yields of total RNA because the concentration of GTP becomes limiting when holding the total concentration of cap and GTP constant.
First, cap analog is very expensive and second, higher nucleotide co

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods and compositions for preparing capped RNA
  • Methods and compositions for preparing capped RNA
  • Methods and compositions for preparing capped RNA

Examples

Experimental program
Comparison scheme
Effect test

example 1

Standard mMmM In Vitro Transcription Reaction

[0104] A standard mMESSAGE mMACHINE® T7 Kit reaction contains 50 ng / μl plasmid template; 4 U / μl T7 RNA polymerase; 0.005 U / μl IPP; 0.03 U / μl RNase Inhibitor; 0.01 U / μl SUPERase•In; 0.1% Chaps; 40 mM Tris, pH 8.0; 20-30 mM MgCl2; 2 mM spermidine; 10 mM DTT; 7.5 mM ATP; 7.5 mM CTP; 7.5 mM UTP; 1.5 mM GTP; and, 6 mM m7GpppG cap analog. Components are assembled at room temperature in a final volume of 20 μl and the reaction is incubated at 37° C. up to two hours. Under these conditions, transcription reactions with pTRI-Xef (˜1.8 kb RNA), pAmbluc (˜1.8 kb RNA) or p4kb (˜4 kb RNA) templates produce ˜30 μg of transcript (˜1.5 mg / ml) in 30 minutes. A time course study with the p4kb template is presented in FIG. 1. Analysis of the RNA produced on a RNA LabChip with the Agilent 2100 bioanalyzer showed no RNA degradation over time.

[0105] The cap:GTP ratio in a standard mMmM reaction is 4:1. Analysis of the capping efficiency confirmed that less t...

example 2

Fed-Batch In Vitro Transcription Reaction—Manual Feed

[0107] The time course study presented in FIG. 1 shows that a standard mMmM reaction is essentially completed after 30 min incubation at 37° C. At this time point, most of the GTP has been incorporated into the transcript. In contrast, only a small fraction of the cap analog has been used as 1) there is a 4-fold excess of cap over GTP in the reaction, 2) only 1 molecule of cap is incorporated per molecule of RNA synthesized, and 3) only ˜80% of the transcripts are capped. The amount of GTP used and the percentage of cap used in the reaction can be easily estimated from the yield and the size of the transcript. The average molecular weight of a given RNA molecule is equivalent to its total number of residues. If this value is multiplied by 320 g / mol (the average molecular weight for all 4 residues), then:

[GTP] used in mM=(3.12×yield×G) / nt

% cap used=(250×yield) / (nt×[cap]) [0108] with yield in μg / μl or mg / ml [0109] G=number of G r...

example 3

Fed-Batch In Vitro Transcription Reaction—Other Cap Analogs

[0114] Any non-extending, mono- or di-nucleotide (i.e., that cannot be incorporated as a 3′ nucleotide in a transcription reaction) can be incorporated as the first nucleotide of a transcript by phage RNA polymerases, and are compatible with the fed-batch strategy. This includes 5′ hydroxyl, monophospate or biotinylated nucleotides, trimethylated cap analog (m2,2,7GpppG), unmethylated cap variant (GpppG), tetraphosphate cap variant (m7GppppG) or other cap variants (e.g. m7GpppA, m7GpppC). Of particular interest are the anti-reverse cap analogs (ARCAs). With the standard cap analog m7GpppG, because of the presence of a 3′-OH on both the m7Guanosine and Guanosine moieties, 30-50% of the initiating dinucleotide is incorporated in a reverse, non-functional orientation (Pasqinelli et al., 1995). ARCA molecules such as m7dGpppG, m7,3′-OMeGpppG, m7,3′-OMeGppppG or m7,2′-OMeGppppG (Stepinski et al., 2001; Jemielity et al., 2003) ar...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Molar densityaaaaaaaaaa
Molar densityaaaaaaaaaa
Molar densityaaaaaaaaaa
Login to view more

Abstract

The present invention concerns methods and compositions for increasing the yield of capped and full-length RNA transcripts produced in in vitro transcription reactions. Such methods and compositions can be used for cost-efficient, large scale production of capped full-length RNA transcripts that can be subsequently translated. Methods and compositions involve reaction conditions that promote such production, and includes the implementation of fed-batch introduction of GTP, which competes with a cap analog.

Description

BACKGROUND OF THE INVENTION [0001] 1. Field of the Invention [0002] The present invention relates generally to the field of molecular biology. More particularly, it concerns methods and compositions for generating high yields of RNA transcripts that have a non-extending nucleotide at their 5′ end, such as a cap analog. [0003] 2. Description of Related Art [0004] In vitro transcription, originally developed by Krieg and Melton (1987) for the synthesis of RNA using an RNA phage polymerase, is an integral part of the variety of techniques used in molecular biology. Typically these reactions include at least a phage RNA polymerase (T7, T3 or SP6), a DNA template containing a phage polymerase promoter, nucleotides (ATP, CTP, GTP and UTP), and a buffer containing a magnesium salt. Since an increase in the yield of these reactions would be beneficial in both time and expense, several groups worked to optimize the yields of RNA synthesized by in vitro transcription by increasing nucleotide ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N15/79C12P19/34
CPCC12N15/79
Inventor LABOURIER, EMMANUELPASLOSKE, BRITTAN L.
Owner ASURAGEN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap